Pioneering Genetic Therapies for Duchenne Muscular Dystrophy
Mission
At ART BioScience we are committed to the development of a new class of therapeutics based on messenger RNA (mRNA) for the treatment of Orphan diseases, primarily Duchenne Muscular Dystrophy
Vision
To be recognized as a leader in the discovery, development and commercialization of novel mRNA therapeutics by leveraging a deep understanding of Duchenne biology, specifically strengthening the musculoskeletal system.
Treat Orphan Diseases,
Primarily Duchenne Muscular Dystrophy
Leadership
Our leadership team has deep and diverse industry knowledge, a passion for science and innovation, and we consistently push the boundaries of scientific excellence and discovery in order to transform lives.
Pipeline
We are advancing innovative mRNA genetic therapeutics for Duchenne Molecular Dystrophy using our proprietary Nano Lipid Particles delivery system
